PCFA Online Community Digest December 2018

PCFA Online Community Digest
December 2018

For our final digest for 2018 we wanted to take the opportunity thank you for being a part of our Online Community.

This year we welcomed over 1300 new members, participated in hundreds of conversations on the Community Forum, delved into new content on the Video Gallery and heard about the latest advancements in research through the weekly Research Blog.

In 2019, we will explore ways to improve the digital platform to keep up with the growing membership and strengthen ways for you to stay connected and engaged.

We wish everyone a safe, relaxing and happy Christmas. Please note that the PCFA office will be closed from Monday 24 December 2018 until Friday 6 January inclusive, opening again on Monday 9 January 2019.

During this time we will not be moderating the forum or posting new articles. We encourage all Online Community members to observe the House Rules and to (as always) respectively engage with one another over this period.

Stay up to date with the latest activity on the PCFA Online Community

Community Forum

The Community Forum is a supportive space to connect with others managing life with prostate cancer.

Read through the latest conversations

“Viagra…. recreation or medication”
“Seeking reassurance.”
“Questionable lymph node”
“Drug treatment after Radio Therapy”
“Libido”

Start a New Conversation

Research Blog

The Research Blog features the latest advances in prostate cancer research.

Ductal prostate cancer: a rare form of prostate cancer

Ductal prostate cancer is a rare type of prostate cancer. Men diagnosed with ductal prostate cancer are more likely to see their cancer spread and more likely…
Read article

diagram to show the ratio of people who stay with active surveillance

Why do men drop out of active surveillance?

Men who are diagnosed with prostate cancer that has already spread are usually treated with hormone therapy and chemotherapy. Treatment of…
Read article

Radiotherapy for men diagnosed with metastatic prostate cancer

Men who are diagnosed with prostate cancer that has already spread are usually treated with hormone therapy and chemotherapy. Treatment of the tumour …
Read article

The US patent for Abiraterone (Zytiga) has been declared invalid

A key US patent for the use of Abiraterone (Zytiga) for treating metastatic prostate cancer has been ruled invalid by a US court. This could lead to cheaper versions…
Read article

Community News and Views

Community News & Views is a roundup of the latest activities and insights that raise community awareness and support those impacted by prostate cancer across Australia.

If you have news about a recent event or activity that you have been involved in, we would love to hear from you.

Share Your News

Click here to forward to a friend